Product Information
PAROXETINE HCL 30 MG TABLET is a generic product labeled by Oxford Pharmaceuticals, LLC, priced at $0.0940 per EA under NDC 69584067390. Its NADAC has been published 180 times since Mar 15, 2023.
FDA first approved this application on Jun 21, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Oxford Pharmaceuticals, LLCNDC
69584067390
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PAROXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076968FDA Approved
6/21/2010
TE Code
AB
On Market Since
11/14/2022
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE HCL 30 MG TABLET has been published 180 times since Mar 15, 2023, and over the history we have for it it has declined 24.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0940 per EA |
|---|---|
| All-time high | $0.1293 (Jun 14, 2023) |
| All-time low | $0.0735 (Nov 20, 2024) |
| 52-week high | $0.1039 |
| 52-week low | $0.0940 |
| Median price | $0.0978 |
| Average price | $0.1009 |
| Largest weekly change | +27.2% (Nov 22, 2023) |
| Weeks tracked | 180 |
| Tracking since | Mar 15, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PAROXETINE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE HCL 30 MG TABLET, manufactured by Oxford Pharmaceuticals, LLC, is $0.0940 per EA (NDC 69584067390), effective Aug 19, 2026.
How has the price of PAROXETINE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE HCL 30 MG TABLET has declined 24.3%. It has been tracked across 180 weekly CMS publications since Mar 15, 2023.
What are the highest and lowest recorded NADAC prices for PAROXETINE HCL 30 MG TABLET?
Since Mar 15, 2023, the NADAC for PAROXETINE HCL 30 MG TABLET has ranged from a low of $0.0735 (Nov 20, 2024) to a high of $0.1293 (Jun 14, 2023), with a median of $0.0978 per EA.
Are there cheaper alternatives to PAROXETINE HCL 30 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PAROXETINE HCL 30 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PAROXETINE HCL 30 MG TABLET?
PAROXETINE HCL 30 MG TABLET (NDC 69584067390) is labeled by Oxford Pharmaceuticals, LLC, and CMS classifies it as a generic product.